Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG

DSpace Repository

Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG

Author: Zaremba, Anne; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Pfoehler, Claudia; Weichenthal, Michael; Terheyden, Patrick; Forschner, Andrea; Leiter, Ulrike; Ulrich, Jens; Utikal, Jochen; Welzel, Julia; Kaatz, Martin; Gebhardt, Christoffer; Herbst, Rudolf; Sindrilaru, Anca; Dippel, Edgar; Sachse, Michael; Meiss, Frank; Heinzerling, Lucie; Haferkamp, Sebastian; Weishaupt, Carsten; Loeffler, Harald; Kreft, Sophia; Griewank, Klaus; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma; Zimmer, Lisa
Tübinger Autor(en):
Forschner, Andrea Lydia
Leiter-Stöppke, Ulrike
Published in: European Journal of Cancer (2023), Bd. 188, S. 140-151
Verlagsangabe: Oxford : Elsevier Sci Ltd
Language: English
Full text: http://dx.doi.org/10.1016/j.ejca.2023.04.008
ISSN: 0959-8049
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)